ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BHVN Biohaven Ltd

47.3099
-0.0201 (-0.04%)
Feb 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 686,976
Bid Price
Ask Price
News -
Day High 49.61

Low
12.35

52 Week Range

High
50.6799

Day Low 47.25
Share Name Share Symbol Market Stock Type
Biohaven Ltd BHVN NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0201 -0.04% 47.3099 19:00:00
Open Price Low Price High Price Close Price Previous Close
48.38 47.25 49.61 47.31 47.33
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
10,621 686,976 US$ 48.43 US$ 33,271,723 - 12.35 - 50.6799
Last Trade Type Quantity Price Currency
18:45:00 4 US$ 47.02 USD

Biohaven (BHVN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-50k

Calls / Puts

50.00%

Buys / Sells

50.00%

OTM / ITM

200.00%

Sweeps Ratio

0.00%

Biohaven Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 3.80B - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Biohaven News

Date Time Source News Article
1/08/202406:30Edgar (US Regulatory)Form 8-K - Current report
1/08/202406:30PR Newswire (US)Biohaven Highlights Progress Across Innovative Portfolio and..
1/02/202406:00PR Newswire (US)Biohaven to Present at the 42nd Annual J.P. Morgan..
12/01/202315:30PR Newswire (US)Biohaven Presents Expanded EEG and Safety Data for BHV-7000..
11/14/202315:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/202315:05PR Newswire (US)Biohaven Reports Third Quarter 2023 Financial Results and..
10/16/202306:00PR Newswire (US)Biohaven Presents Preclinical Data Demonstrating..
10/05/202315:05Edgar (US Regulatory)Form 8-K - Current report
10/05/202315:05PR Newswire (US)Biohaven Announces Closing of Public Offering and Full..
10/04/202315:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202322:56PR Newswire (US)Biohaven Announces Pricing of $225 Million Public Offering..
10/02/202320:41Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BHVN Message Board. Create One! See More Posts on BHVN Message Board See More Message Board Posts

Historical BHVN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week48.9550.679945.2047.56781,641-1.64-3.35%
1 Month45.1050.679943.0546.67763,1982.214.90%
3 Months33.2050.679932.0842.331,056,74314.1142.50%
6 Months19.9150.679916.4532.511,113,90227.40137.62%
1 Year15.2450.679912.3525.801,069,33932.07210.43%
3 Years77.54152.567.1066.41991,342-30.23-38.99%
5 Years45.59152.567.1062.77891,4921.723.77%

Biohaven Description

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com